H.C. Wainwright analyst Arthur He CFA has maintained their bullish stance on PSTX stock, giving a Buy rating today. Arthur He CFA has given ...

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...

Of note, unlike other CAR T-cell therapies, the CD19-directed genetically modified autologous T-cell ... at least two ...

William Blair analyst Sami Corwin has maintained their bullish stance on PSTX stock, giving a Buy rating on November 8. Sami Corwin has given ...

The global cell and gene therapy market size was valued at USD 30.27 billion in 2024 and is projected to reach USD 190.82 ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

Analysis By Type, By Stem Cell Source, By Application, By End User, By Region Size and Trends Forecast up to 2029" report has ...

TrakCel, a provider of integrated cell and gene therapy (CGT) orchestration solutions for the precise management, control and tracking of CGTs has today announced that its orchestration platform ...

ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing cells currently being investigated in non-Hodgkin's lymphoma (NHL) The planned clinical study will be executed ...